• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

环拉马朵。平衡麻醉期间的治疗剂量范围。

Ciramadol. The therapeutic dose range during balanced anesthesia.

作者信息

Camu F, Heytens L, Claeys M A

出版信息

Acta Anaesthesiol Belg. 1985 Mar;36(1):23-31.

PMID:3839340
Abstract

In this study we attempted to determine whether ciramadol, a mixed opioid agonist-antagonist, would provide a satisfactory analgesic supplementation to an anesthetic technique for major surgery. Fourteen surgical patients received a balanced anesthesia technique with nitrous oxide, oxygen and muscle relaxants following thiopental induction. Incremental doses of ciramadol were administered as indicated by the somatic, hemodynamic or other sympathetic responses to anesthetic and surgical stimulations. The mean requirements of ciramadol during surgery were inferred from each patient's time-dose curve. The mean loading dose of ciramadol needed was 2.5 +/- 0.4 mg/kg and for maintenance of the analgesic effects, ciramadol had to be administered at a rate of 0.41 +/- 0.09 mg/kg.h. The important transformation rate (50.4%/h) was suggestive of an analgetic ceiling effect. Despite the very large amounts of ciramadol given, the hemodynamic responses to noxious stimuli were not fully suppressed with hypertensive episodes occurring during surgery. Recovery of spontaneous ventilation appeared promptly after completion of surgery and no evidence of respiratory depression was seen. Minute ventilation, respiratory rate and arterial PaCO2 remained within normal limits up to two hours after the end of anesthesia. No incidence of adverse psychotomimetic effects was observed.

摘要

在本研究中,我们试图确定环拉朵(一种混合阿片类激动剂 - 拮抗剂)是否能为大型手术的麻醉技术提供令人满意的镇痛补充。14名手术患者在硫喷妥钠诱导后接受了氧化亚氮、氧气和肌肉松弛剂的平衡麻醉技术。根据对麻醉和手术刺激的躯体、血流动力学或其他交感神经反应,给予递增剂量的环拉朵。手术期间环拉朵的平均需求量由每位患者的时间 - 剂量曲线推断得出。所需环拉朵的平均负荷剂量为2.5±0.4mg/kg,为维持镇痛效果,环拉朵必须以0.41±0.09mg/kg·h的速率给药。重要的转换率(50.4%/h)提示存在镇痛天花板效应。尽管给予了大量的环拉朵,但手术期间仍出现高血压发作,对有害刺激的血流动力学反应未得到充分抑制。术后自主通气迅速恢复,未观察到呼吸抑制的证据。麻醉结束后两小时内,分钟通气量、呼吸频率和动脉血二氧化碳分压均保持在正常范围内。未观察到不良拟精神作用的发生。

相似文献

1
Ciramadol. The therapeutic dose range during balanced anesthesia.环拉马朵。平衡麻醉期间的治疗剂量范围。
Acta Anaesthesiol Belg. 1985 Mar;36(1):23-31.
2
Ciramadol as analgesic adjunct to anesthesia in short surgical procedures.环拉马朵在短小手术中作为麻醉辅助镇痛药。
Acta Anaesthesiol Belg. 1985 Dec;36(4):381-9.
3
Low ceiling respiratory depression by ciramadol.环拉马朵引起的低封顶效应呼吸抑制
Int J Clin Pharmacol Res. 1986;6(6):451-5.
4
Comparative evaluation of ciramadol (WY-15.705), morphine and placebo for treatment of postoperative pain.环拉马多(WY-15.705)、吗啡与安慰剂治疗术后疼痛的比较性评估
Acta Anaesthesiol Belg. 1985 Jun;36(2):97-110.
5
Comparative evaluation of morphine, pentazocine and ciramadol in postaddicts.吗啡、喷他佐辛和环拉马朵在戒毒者中的比较评价。
J Pharmacol Exp Ther. 1987 Mar;240(3):900-10.
6
A double-blind comparison of multiple intramuscular doses of ciramadol, morphine, and placebo for the treatment of postoperative pain.
Anesth Analg. 1985 Nov;64(11):1101-7.
7
Variable rate infusion of alfentanil as a supplement to nitrous oxide anesthesia for general surgery.
Anesth Analg. 1983 Nov;62(11):982-6.
8
Effects of intravenous patient-controlled analgesia with buprenorphine and morphine alone and in combination during the first 12 postoperative hours: a randomized, double-blind, four-arm trial in adults undergoing abdominal surgery.术后12小时内单独及联合使用丁丙诺啡和吗啡静脉自控镇痛的效果:一项针对接受腹部手术的成年人的随机、双盲、四臂试验。
Clin Ther. 2009 Mar;31(3):527-41. doi: 10.1016/j.clinthera.2009.03.018.
9
Anesthetic effects of tiletamine-zolazepam, alone or in combination with butorphanol, in goats.替来他明-唑拉西泮单独或与布托啡诺联合使用对山羊的麻醉效果。
J Am Vet Med Assoc. 1997 Sep 1;211(5):593-7.
10
Ciramadol. A new analgesic.环拉马朵。一种新型镇痛药。
Med J Aust. 1979 Nov 3;2(9):501-2.